The pharma firm, which is focused on neuroscience, is undertaking a search for a new permanent CEO to replace Remi Barbier, who resigned from the company and the board. Shares of Cassava Sciences ...

Cassava Sciences and two former executives agreed ... In addition to the $40 million settlement from Cassava, then-CEO Remi Barbier agreed to pay $175,000. (A former senior vice president was ...

The US financial regulator has accepted a $40 million-plus settlement from Cassava Sciences and two of its ... Cassava's founder and former chief executive Remi Barbier and former head of ...

Alzheimer’s drug developer Cassava Sciences (NASDAQ ... interesting to do it again at some point in the future,” CEO Remi Barbier remarked. Cassava (SAVA) expects to use the net proceeds ...

Cassava Sciences’ stock has dropped by more ... founder and former CEO, Remi Barbier, and the former Senior Vice President of Neuroscience, Dr. Lindsay Burns. A separate SEC case was set out ...

Cassava Sciences, Inc. engages in the development ... The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Cassava Sciences’ SAVA stock shed more than 80 ... including founder and ex-CEO Remi Barbier and former senior vice president of Neuroscience, Dr. Lindsay Burns. They were accused of negligence ...

Cassava Sciences stock plummeted Monday — wiping out more than three-quarters of its value — after the company's Alzheimer's treatment failed in Phase 3 testing. Please watch the video at ...

Cassava Sciences, Inc. engages in the development ... The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Cassava Sciences, Inc. engages in the development ... The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.